Optimisation of prime-boost immunization in mice using novel protein-based and recombinant vaccinia (Tiantan)-based HBV vaccine.
<h4>Background</h4>A therapeutic vaccine for chronic hepatitis B virus (HBV) infection that enhances virus-specific cellular immune responses is urgently needed. The "prime-boost" regimen is a widely used vaccine strategy against many persistence infections. However, few report...
Guardado en:
Autores principales: | Hong Chen, Xia Chuai, Yao Deng, Bo Wen, Wen Wang, Shaoqing Xiong, Li Ruan, Wenjie Tan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7df43b65b6dd4569ab70422fdcfff997 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genomic sequence and virulence of clonal isolates of vaccinia virus Tiantan, the Chinese smallpox vaccine strain.
por: Qicheng Zhang, et al.
Publicado: (2013) -
Elicitation of both anti HIV-1 Env humoral and cellular immunities by replicating vaccinia prime Sendai virus boost regimen and boosting by CD40Lm.
por: Xianfeng Zhang, et al.
Publicado: (2012) -
Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis.
por: Noushin Saljoughian, et al.
Publicado: (2013) -
Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination.
por: Sjoerd H E van den Worm, et al.
Publicado: (2012) -
Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
por: Ros Chapman, et al.
Publicado: (2021)